Toward Norepinephrine as a First-Line Treatment for All Hospitalized Patients With Hepatorenal Syndrome

Liver Transpl. 2021 Aug;27(8):1087-1088. doi: 10.1002/lt.26106. Epub 2021 Jul 2.

Authors

Cary H Paine¹, Raimund H Pichler, Laura Evans, Scott W Biggins

Affiliation

¹ Division of Nephrology University of Washington Seattle WA Center for Liver Investigation Fostering Discovery University of Washington Seattle WA Division of Pulmonary and Critical Care Medicine University of Washington Seattle WA Division of Gastroenterology and Hepatology University of Washington Seattle WA.

PMID: 34028156
DOI: 10.1002/lt.26106

No abstract available

Publication types

Editorial
Comment

MeSH terms

Hepatorenal Syndrome* / drug therapy
Humans
Liver Transplantation*
Lypressin
Norepinephrine / therapeutic use
Terlipressin

Substances

Lypressin
Terlipressin
Norepinephrine